Get started
Author

Christine Brunner

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
2021 · Michael Gnant, Florian Fitzal, et al. · New England Journal of Medicine · 162
PDF
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
2022 · Michael Gnant, Sophie Frantal, et al. · NEJM Evidence · 54
Resistance to HER2-targeted therapy: mechanisms of trastuzumab resistance and possible strategies to overcome unresponsiveness to treatment
2010 · Michael Hubalek, Christine Brunner, et al. · Wiener Medizinische Wochenschrift · 50
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study
2024 · Christine Brunner, Marjan Arvandi, et al. · Journal of Clinical Oncology · 41
PDF
Quantitative Proteomic Characterization of Foreign Body Response towards Silicone Breast Implants Identifies Chronological Disease-Relevant Biomarker Dynamics
2023 · Ines Schoberleitner, Klaus Faserl, et al. · Biomolecules · 21
PDF
Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial.
2022 · Michael Gnant, Sophie Frantal, et al. · Journal of Clinical Oncology · 19
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort
2022 · Aparna Gunda, Chetana Basavaraj, et al. · The Breast · 19
PDF
Silicone implant surface microtopography modulates inflammation and tissue repair in capsular fibrosis
2024 · Ines Schoberleitner, Klaus Faserl, et al. · Frontiers in Immunology · 17
Is It All about Surface Topography? An Intra-Individual Clinical Outcome Analysis of Two Different Implant Surfaces in Breast Reconstruction
2023 · Ines Schoberleitner, Angela Augustin, et al. · Journal of Clinical Medicine · 17
PDF
Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, randomized trial
2024 · Christine Brunner, Miriam Emmelheinz, et al. · The Breast · 16
PDF
The impact of dexamethasone as a perineural additive to ropivacaine for PECS II blockade in patients undergoing unilateral radical mastectomy – A prospective, randomized, controlled and double-blinded trial
2021 · Elisabeth Hoerner, Lukas Gasteiger, et al. · Journal of Clinical Anesthesia · 16
Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study
2016 · V. Colleselli, T. Nell, et al. · Archives of Gynecology and Obstetrics · 13
PDF
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
2025 · Gabriel Rinnerthaler, Daniel Egle, et al. · Nature Cancer · 12
PDF
Surface Topography, Microbial Adhesion, and Immune Responses in Silicone Mammary Implant-Associated Capsular Fibrosis
2024 · Ines Schoberleitner, Leoni Baier, et al. · International Journal of Molecular Sciences · 12
PDF
Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
2022 · Christine Brunner, Miriam Emmelheinz, et al. · The Breast · 11
PDF
Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival
2022 · Albertini Carmen, Oberguggenberger Anne, et al. · Breast Cancer Research and Treatment · 10
PDF
Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
2022 · Angela Augustin, Petra Pülzl, et al. · Current Oncology · 9
PDF
Long-Term Outcome Analysis and Technical Refinements after Autologous Breast Reconstruction with PAP Flap: What We Have Learnt
2022 · Evi M. Morandi, Selina Winkelmann, et al. · Breast Care · 9
PDF
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.
2025 · Christian F. Singer, Dominik Hlauschek, et al. · Journal of Clinical Oncology · 4
PRO Hair Safe Study: The Patient’s Perspective on the Effects of Scalp Cooling on Hair Preservation
2023 · Christine Brunner, Daniel Egle, et al. · Breast Cancer Targets and Therapy · 4
PDF
Targeted Axillary Dissection Using Surgical Marker Navigation after Neoadjuvant Systemic Treatment in Breast Cancer Patients: A Single-Center Experience
2025 · Daniel Egle, Christine Brunner, et al. · Breast Care · 3
PDF
REACHAUT: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) in the real-world setting.
2019 · Christian F. Singer, Leopold Öhler, et al. · Journal of Clinical Oncology · 3
Comparison of Efficacy and Safety of Cryotherapy in Chemotherapy-Induced Peripheral Neuropathy Between Upper and Lower Extremities: Results from the Randomized CROPSI Study
2025 · Miriam Emmelheinz, Christian Marth, et al. · Cancers · 2
PDF
A Prospective Comparison of Subjective Symptoms and Neurophysiological Findings in the Assessment of Neuropathy in Cancer Patients
2024 · Vera Elisabeth Adreana Kleinveld, Miriam Emmelheinz, et al. · Diagnostics · 2
PDF
Abstract PO3-16-10: Real-world outcomes with first-line ribociclib + endocrine therapy in patients with metastatic HR+, HER2– breast cancer: Fourth interim analysis of REACH AUT trial
2024 · Christian F. Singer, Daniel Egle, et al. · Cancer Research · 2
Works count: 55
Citation count: 540
H-index: 12
I10-index: 16
Year
Topic
Type